BTIG analyst Ryan Zimmerman upgraded Solventum (SOLV) to Buy from Neutral with a $100 price target The firm believes the company will find its “footing” in 2026. The company’s divestiture of its purification and filtration business helped reduce its debt, says BTIG, which cites Solventum’s execution against guidance and reduced buy-side expectations for the upgrade. It finds the stock’s setup “compelling” at current valuation levels.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum upgraded to Buy from Neutral at BTIG
- Solventum Corporation: Hold Rating Amid Strategic Moves and Growth Challenges
- Strategic Acquisition and Capital Management Propel Solventum Corporation’s Growth Potential
- Solventum announces $1B share repurchase program
- Solventum to acquire Acera Surgical